BIO-key(BKYI) - 2025 Q3 - Quarterly Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Table of Contents DELAWARE 41-1741861 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Its Charter) WASHINGTON, D.C. 20549 FORM 10-Q Indicate b ...